In this Section |
235331 Home distribution of hormonal contraceptives by public health nursesWednesday, November 2, 2011: 8:30 AM
Home based distribution of contraceptives is a recognized intervention used in developing countries to prevent unintended pregnancy. To our knowledge, this intervention is not widely or systemically practiced in the United States for several reasons, including concerns about scope of practice of health workers and nurses. Our study is a multisite randomized clinical trial evaluating home-based distribution of hormonal contraceptives by public health nurses through the Nurse Family Partnership home visiting program. These contraceptives include pills, patches, vaginal rings and depomedroxyprogesterone injections. Although our results are preliminary, we believe that giving the nurses the ability to distribute hormonal contraception in the home has enabled nurses to improve access to contraceptive options, increase knowledge of hormonal contraceptive options and bring about change in the reproductive health behavior of women at risk for unintended pregnancy. We will describe development of our clinical protocol, how we trained nurses in the protocol, and facilitators and barriers nurses experienced in adopting the practice. Lessons learned from our study will be useful in other public health settings within the United States.
Learning Areas:
Administration, management, leadershipDiversity and culture Public health or related laws, regulations, standards, or guidelines Public health or related nursing Public health or related organizational policy, standards, or other guidelines Public health or related research Learning Objectives: Keywords: Contraception, Home Visiting
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am Principal Investigator on the study and I am responsible for clinical oversight of family planning programs. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Contraceptive Methods, Use and Services
See more of: Population, Reproductive and Sexual Health |